Antidepressant adherence and influencing factors among pregnant women: a retrospective cohort study in Lleida, Spain

dc.contributor.author
Perejón López, Daniel
dc.contributor.author
Siscart Viladegut, Júlia
dc.contributor.author
Serna Arnaiz, Catalina
dc.contributor.author
Orós Ruiz, Miriam
dc.contributor.author
Galván Santiago, Leonardo
dc.contributor.author
Sol Cullere, Joaquim
dc.contributor.author
Salinas-Roca, Blanca
dc.date.accessioned
2025-12-15T19:28:34Z
dc.date.available
2025-12-15T19:28:34Z
dc.date.issued
2025-09
dc.identifier
https://doi.org/10.1080/09581596.2025.2563146
dc.identifier
1469-3682
dc.identifier
0958-1596
dc.identifier
https://hdl.handle.net/10459.1/469223
dc.identifier.uri
http://hdl.handle.net/10459.1/469223
dc.description.abstract
Depression is the most common psychological illness in the perinatal period. Low adherence to treatment has been associated with health problems for the mother and the child. To analyse adherence to antidepressant treatment in pregnant women and identify possible factors associated with adherence. Retrospective observational cohort study in pregnant women in the Region of Lleida from 2012 to 2018. Variables: age, body mass index (BMI), hypothyroidism, arterial hypertension, diabetes mellitus, dyslipidaemia, country of origin, and prescribed antidepressant drug and adherence to it. A multivariate analysis and obtained the linear regression coefficients and their 95% confidence interval (CI) was estimated. In a sample of 17177 pregnant women, 2.5% had a diagnosis of a depressive disorder and 24% have a prescribed antidepressant treatment. Of these, 25% showed an adequate adherence to it. No relationship was observed between therapeutic adherence and the other variables, such as age, BMI, diabetes mellitus, and country of origin. This study revealed a notable occurrence of depression in pregnant women. Treatment uptake aligns with rates observed in similar groups; however, adherence to prescribed regimens remains considerably low. These findings highlight the need for further investigation into barriers impacting treatment compliance, with the aim of enhancing care effectiveness for this vulnerable population.
dc.language
eng
dc.publisher
Taylor & Francis
dc.relation
Reproducció del document publicat a https://doi.org/10.1080/09581596.2025.2563146
dc.relation
Critical Public Health, 2025, vol. 35, núm. 1, 2563146
dc.rights
cc-by-nc, (c) Daniel Perejón López et al., 2025
dc.rights
Attribution-NonCommercial 4.0 International
dc.rights
info:eu-repo/semantics/openAccess
dc.rights
http://creativecommons.org/licenses/by-nc/4.0/
dc.subject
Antidepressants
dc.subject
Pregnancy
dc.subject
Therapeuticadherence
dc.title
Antidepressant adherence and influencing factors among pregnant women: a retrospective cohort study in Lleida, Spain
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)